The Gaussian prior is the wrong size
Coordinate-space diffusion models start from N(0, σT²I). In 3n dimensions that noise sits on a thin shell of radius σT√3n — fixed by the noise level and atom count, not by chemistry.
The sampler must then drift a long, wandering way back to a molecule-sized structure — and the mismatch grows with n.
Start on a chemically scaled shell
SSD places every atom on a spherical shell of radius rSSD, calibrated to the mean radius of centred training conformations — 6.37 Å on QM9, 21.16 Å on Drugs.
It is one dataset-level constant (a per-molecule radius would break the prior's role as a marginal). Atoms get a random shell assignment π per trajectory — deterministic matching collapses coverage.
A uniform-speed pull onto the shell
The forward SDE replaces Gaussian drift with a normalised directional attraction: each atom moves toward its assigned shell point at speed αt, whatever its distance.
Unlike Ornstein–Uhlenbeck's exponential pull, every atom arrives on the same schedule — a thin forward shell, so training noise already looks like SSD's prior.
Three structured drifts, back to a molecule
Sampling starts from the same shell and combines radial attraction (a uniform inward pull), short-range repulsion (atoms never closer than dmin) and an SE(3)-equivariant score that refines local geometry.
The added drifts are closed-form and depend only on directions and pairwise offsets, so equivariance is preserved and no learnable parameters are added.
One framework, five backbones
SSD drops into GeoDiff, SubGDiff, EDM, SemlaFlow-style flow matching and MCF — each evaluated under its own canonical protocol, with identical training and sampling budgets.
Every backbone improves; GeoDiff on Drugs jumps from 64.1 → 91.7 COV-R, and EDM's QM9 molecule stability from 82.0 → 99.8%. The ablation confirms neither the shell nor the drifts alone get there.
Shorter paths, bigger molecules
Trajectories become direct: SubGDiff's path-excess ratio drops from 246.9 to 1.71. SSD converges faster in training, stays strong at just 20 sampling steps, and its gains grow with size — +32.5 COV-R on ≥50-atom drug-like molecules.